ABHI (Association of British Health-Care Industries) philosophical over drugs-focused NICE (UK National Institute for Clinical Excellence):
This article was originally published in Clinica
Has the balance shifted towards the drugs industry?" This is one of the questions that Gordon Aylward, director general of the Association of British Health-Care Industries (ABHI), posed to medical device industry members during a satellite session of NICE's annual conference - Clinical Excellence 2001 - in London last week. If so, "the answer may lie in the fact that medical devices are the perfect team-working product. Assessment of the patient is likely to be far more rigorous in the use of a medical device than in a drug," said Mr Aylward. We must accept that our place in the NHS is not necessarily at its centre, but as an important supplier to it."
You may also be interested in...
Abbott is launching a second test to detect COVID-19. The diagnostics giant announced on 27 March the release of a rapid, point-of-care test that can deliver results within five minutes.
President Trump on 27 March finally pulled the trigger on using his powers under the Defense Production Act, forcing General Motors Co. to manufacture medical ventilators. The only thing is, GM is already doing that.
Theradaptive's “paint-like” regenerative therapeutic can be applied to any device to promote bone regrowth or regenerate tissue.